Yayın:
Real-life comparison of afatinib and erlotinib in non-small cell lung cancer with rare EGFR exon 18 and exon 20 mutations: a Turkish Oncology Group (TOG) study

Sadeleştirilmiş öğe sayfası
dc.contributor.authorTurhal, Serdal
dc.contributor.authorAli Murat Tatlı
dc.contributor.authorDi̇lek Erdem
dc.contributor.authorErdem Göker
dc.contributor.authorEmir Çelik
dc.contributor.authorNebi Serkan Demirci
dc.contributor.authorAbdullah Sakin
dc.contributor.authorMuhammed Mustafa Atçı
dc.contributor.authorErtuğrul Bayram
dc.contributor.authorTuğba Akın Telli
dc.contributor.authorBurak Bi̇lgi̇n
dc.contributor.authorAhmet Bılıcı
dc.contributor.authorBaran Akangunduz
dc.contributor.authorSevinç Ballı
dc.contributor.authorAhmet Demirkazık
dc.contributor.authorFatih Selçukbırıcık
dc.contributor.authorSerkan Menekşe
dc.contributor.authorEyyüp Çavdar
dc.contributor.authorAkın Öztürk
dc.contributor.authorEsma Türkmen Bekmez
dc.contributor.authorSerdal Turhal
dc.contributor.authorSadettin Kılıçkap
dc.contributor.authorHasan Çağrı Yıldırım
dc.contributor.authorBaşak Oyan
dc.contributor.authorAsude Aksoy
dc.contributor.authorFatma Paksoy Türköz
dc.contributor.authorEngin Kut
dc.contributor.authorNuran Katgı
dc.contributor.authorTeoman Şakalar
dc.contributor.authorMurat Akyol
dc.contributor.authorHalil İbrahim Ellez
dc.contributor.authorAtakan Topçu
dc.contributor.authorAtike Pınar Erdoğan
dc.contributor.authorKezban Nur Pilancı
dc.contributor.authorEngin Hedem
dc.contributor.authorHacı Arak
dc.contributor.authorNadiye Akdeniz
dc.contributor.authorÖzkan Alan
dc.contributor.authorBurcu Yapar
dc.contributor.authorDenız Nart
dc.contributor.authorPerran Fulden Yumuk
dc.contributor.orcid0000-0003-1392-6753
dc.contributor.orcid0000-0001-9696-1102
dc.contributor.orcid0000-0001-6495-6712
dc.contributor.orcid0000-0001-6180-713X
dc.contributor.orcid0000-0001-8440-3082
dc.contributor.orcid0000-0001-5943-889X
dc.contributor.orcid0000-0003-2538-8569
dc.contributor.orcid0000-0002-1300-3695
dc.contributor.orcid0000-0001-8713-7613
dc.contributor.orcid0000-0001-6535-6030
dc.contributor.orcid0000-0003-1717-8246
dc.contributor.orcid0000-0002-0443-6966
dc.contributor.orcid0000-0002-1273-1674
dc.contributor.orcid0000-0002-2134-2128
dc.contributor.orcid0000-0001-5885-3047
dc.contributor.orcid0000-0002-3445-3804
dc.contributor.orcid0000-0003-3060-377X
dc.contributor.orcid0000-0002-5609-9658
dc.contributor.orcid0000-0002-5328-5607
dc.contributor.orcid0000-0003-0028-8991
dc.contributor.orcid0000-0003-2749-9414
dc.contributor.orcid0000-0003-0886-3559
dc.contributor.orcid0000-0002-9593-0942
dc.contributor.orcid0000-0002-3634-4820
dc.contributor.orcid0000-0003-4859-7574
dc.contributor.orcid0000-0002-0901-819X
dc.contributor.orcid0000-0002-2023-423X
dc.contributor.orcid0000-0002-4597-9721
dc.contributor.orcid0000-0002-6635-2012
dc.contributor.orcid0000-0002-8100-6978
dc.contributor.orcid0000-0001-8650-299X
dc.date.accessioned2025-11-13T11:37:40Z
dc.date.issued2022-04-05
dc.identifier.doihttps://doi.org/10.1007/s00432-022-03984-5
dc.identifier.endpage875
dc.identifier.issn0171-5216
dc.identifier.issue2
dc.identifier.openalexW4226033077
dc.identifier.startpage865
dc.identifier.urihttps://hdl.handle.net/11421/7421
dc.identifier.urihttps://doi.org/10.1007/s00432-022-03984-5
dc.identifier.volume149
dc.language.isoen
dc.relation.ispartofJournal of Cancer Research and Clinical Oncology
dc.rightsopenAccess
dc.subjectAfatinib
dc.subjectExon
dc.subjectErlotinib
dc.subjectMedicine
dc.subjectLung cancer
dc.subjectInternal medicine
dc.subjectErlotinib Hydrochloride
dc.subjectOncology
dc.subjectGefitinib
dc.subjectEpidermal growth factor receptor
dc.subjectMutation
dc.subjectCancer
dc.subjectBiology
dc.subjectGenetics
dc.subjectGene
dc.subject.sdg3
dc.titleReal-life comparison of afatinib and erlotinib in non-small cell lung cancer with rare EGFR exon 18 and exon 20 mutations: a Turkish Oncology Group (TOG) study
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5019906736

Dosyalar

Koleksiyonlar

Publications